These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18591520)

  • 1. Breast cancer rises in India.
    Bagchi S
    CMAJ; 2008 Jul; 179(1):27. PubMed ID: 18591520
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for breast cancer in India--is it an appropriate strategy?
    Moss S
    J Natl Cancer Inst; 2008 Sep; 100(18):1270-1. PubMed ID: 18780862
    [No Abstract]   [Full Text] [Related]  

  • 3. A study on time trends in incidence of breast cancer - Indian scenario.
    Murthy NS; Agarwal UK; Chaudhry K; Saxena S
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):185-6. PubMed ID: 17371429
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological clues from screening.
    De Waard F
    J Med Screen; 1997; 4(1):2. PubMed ID: 9200053
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening mammography for women ages 40 to 49 years.
    Timins JK
    N J Med; 1997 Apr; 94(4):39-43. PubMed ID: 9108723
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer screening practice of Chinese elderly worth re-evaluation of health promotion policy.
    Chor JS; Leung JC; Chan DC; Leung PC; Griffiths S
    J Public Health (Oxf); 2008 Mar; 30(1):110-1. PubMed ID: 18211917
    [No Abstract]   [Full Text] [Related]  

  • 8. Do I have breast cancer?
    Fountain M
    Nurs Manage; 2000 Apr; 31(4):34-7. PubMed ID: 15127638
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation.
    Ulloa-Pérez E; Mohar-Betancourt A; Reynoso-Noverón N
    Rev Invest Clin; 2016; 68(4):184-91. PubMed ID: 27623037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer, the most frequent and the deadliest of all cancers in women].
    Roussanne C
    Rev Infirm; 2004 Jun; (102):20-7. PubMed ID: 15984730
    [No Abstract]   [Full Text] [Related]  

  • 11. Mammography screening under 50: a limited perspective on a multifaceted issue.
    Royak-Schaler R; Gallant SJ; Klabunde CN
    Womens Health; 1996; 2(4):243-9; discussion 261-6. PubMed ID: 9421559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal breast cancer in split region of Croatia on the eve of the National Mammographic Screening Program.
    Bezić J; Tomić S; Kardum G
    Breast J; 2009; 15(4):429-31. PubMed ID: 19470137
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mammographic screening with the assessment of risk factors and incidence of BRCA-associated breast cancer in the Republic of India].
    Ternovoĭ SK; Matkhev S; Meladze NV; Solopova AE; Abduraimov AB; Les'ko KA
    Vestn Rentgenol Radiol; 2012; (5):16-21. PubMed ID: 23516880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for breast cancer in Iran: a challenge for health policy makers.
    Mousavi SM; Harirchi I; Ebrahimi M; Mohagheghi MA; Montazeri A; Jarrahi AM; Gouya MM; Miller AB
    Breast J; 2008; 14(6):605-6. PubMed ID: 19000044
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementation of screening as a public health policy: issues in design and evaluation.
    Hakama M; Pukkala E; Söderman B; Day N
    J Med Screen; 1999; 6(4):209-16. PubMed ID: 10693068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on "Mammography screening: prospects and opportunity costs".
    Mettlin C
    Womens Health; 1996; 2(4):251-5; discussion 261-6. PubMed ID: 9453857
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiogenic breast cancer effects of mammographic screening.
    Gohagan JK; Darby WP; Spitznagel EL; Monsees BS; Tome AE
    J Natl Cancer Inst; 1986 Jul; 77(1):71-6. PubMed ID: 3459927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening women at moderate risk of breast cancer.
    Moyle P; Warren R
    Br J Hosp Med (Lond); 2007 Nov; 68(11):584-8. PubMed ID: 18087844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.